Skip to content

Clinical trials

Phase 3 Severe Acute Respiratory Syndrome trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Phase: Phase 3 Status: Unknown status Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20207
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardresearch2
Bharat Biotech International Limited1
Biomed Industries, Inc.1
Emory University1
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation1
Hanna Czajka1
MGC Pharmaceuticals d.o.o1
Massimo Girardis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-199
Severe Acute Respiratory Syndrome9
Coronavirus Infections2
Critical Illness1
Cytokine Release Syndrome1
Hemostatic Disorders1
Pneumonia1
Pneumonia, Viral1
Virus Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.